Login

Investing in Space Startups|Jason Whitmire,Co-Founder & General Partner,BlueYard Capital 00:10:00

Share On Facebook Share On Twitter

General Partner and Co-Founder at BlueYard Capital.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Speech by CEO Thomas Müller at the HENSOLDT Annual General Meeting 2021 | Thomas Müller - CEO of HENSOLDT AG
00:10:00
SolGold: Ecuadorian Copper Exploration and Development
00:10:00
PECVD 200™ & FEL 200™: High-Performance Plasma CVD System | Emmanuel Lakios, President and CEO of CVD Equipment Corp
00:10:00
Healthspire CEO Mike LaMena at MarketCounsel Summit |Mike LaMena, CEO, Wealthspire Advisors.
00:10:00
Strategies for Navigating Economic Uncertainty: A Practical Perspective | Tim Buckley, CEO , Vanguard .
00:10:00
Transforming Manufacturing and Industrial Businesses|David Shapiro,Managing Partner, KPS Capital Partners
00:10:00
Digital Transformation: Insights from Marc Radulovic, Senior Operations Manager at Marcura | Gary Vogel - CEO of Eagle Bulk Shipping Inc.
00:10:00
Duos Technologies Group Inc (NASDAQ) CEO Chuck Ferry and COO Scott Carns announce a new contract award during an interview with Proactive.|Charles (Chuck) Ferry is Chief Executive Officer of Duos Technologies Group Inc
00:10:00
Fortune Minerals Secures $16.2M Funding for Nico Project Expansion
00:10:00
Vertex Ventures SEAI - The Leading Global VC for Southeast Asia and India|Ben MATHIAS,Managing Partner,Vertex Fund
00:10:00
Celebrating Volunteer Excellence and Community Impact in the Northwest Territories
00:10:00
Empowering Investors: State Street Global Advisors Expands Investor Voting Choice Program | Yie-Hsin Hung, CEO , State Street Global Advisors.

© 2017 - Neuhu+